Cell and Gene Outsourcing

  1. A Robust And Scalable Suspension Platform For AAV Manufacturing

    Review the demands for AAV manufacturing using a suspension process and the DOE-based strategy used to achieve a scalable process both in terms production and quality of AAV purified.

  2. Building A Strong Safety Culture In The Biopharmaceutical Industry 1/25/2025

    Explore how fostering a strong safety culture — rooted in accountability, collaboration, and proactive risk management — can drive operational excellence and long-term success in biopharmaceuticals.

  3. Sustainable Approaches To Oligonucleotide Manufacturing

    An industry expert shares about sustainable Oligo manufacturing approaches that can save time, cost, and resources – while improving purity, quality, and scalability of these promising therapeutics.

  4. Viral Vector Manufacturing: Improve Efficiency With A Platform Approach 9/25/2023

    Learn more about the platform-based scalable suspension process for LVV production and how it is impacting CGTs advancing toward commercialization.

  5. AAV Analytics: Key Considerations When Developing A Clinical Program 4/25/2024

    Finding partners with the necessary skills to optimize AAV processes is crucial for minimizing risk. Explore key considerations for advancing your therapy from concept to commercialization.

  6. The CDMO Value Proposition For Your Autologous Cell Therapy

    This panel session features a decade-long story of partnership in bringing two life-changing gene therapies to market successfully in 2022.

  7. Early Preclinical Development: A Successful Transition To cGMP Manufacturing 12/2/2024

    Explore the development steps that lead to an mRNA construct optimized for your requirements and that meets future-proof cGMP manufacturing requirements, thereby de-risking the development.

  8. Candidate Screening And Feasibility Studies For Viral Gene Therapies

    Create a simple, modular path to cGMP manufacturing that minimizes risk. Explore a strategic approach for early-stage development and how it can propel therapies to the clinic and the market.

  9. Meeting Needs And Exceeding Expectations Worldwide 10/16/2024

    Whether you are looking to optimize your existing formulations or require full-scale manufacturing solutions, Boehringer Ingelheim BioXcellence™ is dedicated to helping you realize your vision and deliver impactful therapies.

  10. Selecting Containers For Sensitive And Costly Cell & Gene Therapies

    Explore the challenges related to packaging of cell and gene therapy products and proven solutions to enable speed to market and compatibility, performance of packaging materials.